Header image
![](/sites/default/files/styles/page_header_image/public/2023-07/foto_zahlavi_research_1.jpg?itok=p7pBtlZR)
Olaparib is effective in combination with, and as maintenance therapy after, first-line endocrine therapy in prostate cancer cells
Olaparib is effective in combination with, and as maintenance therapy after, first-line endocrine therapy in prostate cancer cells.
Molecular Oncology.
2018,
12(4),
561-576,
ISSN: 1574-7891,
PMID: 29465803,